This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract has a total ceiling value of $1,145,674.30 and a period of performance through July 31, 2025.
The BPA is for the provision of accessories, reagent kits, consumables, supplies, and maintenance services for SARS-CoV-2, hepatitis C, HIV, and hepatitis B PCR testing. It was awarded under the General Services Administration (GSA) Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits. The contract does not utilize any set-aside designations. As an experienced provider of molecular diagnostics to federal agencies, Abbott Molecular has supported the VA, Centers for Disease Control and Prevention, and Department of the Army with a range of testing equipment, reagents, and services. The task orders issued under this BPA have firm fixed-price ceilings ranging from $296,287.73 to $398,718.65 and performance periods from one to three years, reflecting the VA's ongoing need for these critical diagnostic capabilities.
Generated 11/26/24, 9:03 AM